跳至主要内容
临床试验/NCT02885883
NCT02885883已完成不适用

Non-invasive Quantification of Atrial Fibrosis by MRI in Atrial Fibrillation

Assistance Publique Hopitaux De Marseille1 个研究点 分布在 1 个国家目标入组 31 人开始时间: 2011年7月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
31
试验地点
1
主要终点
quantitative measure of atrial fibrosis

研究概览

简要总结

Three groups of patients will be considered: a control group (n = 10); a group of patients with paroxysmal or persistent AF with AF cryoablation procedure - within this group, MRI will replace CT-scan usually performed in routine before the procedure (n = 15); a group of patients with permanent AF (n = 15). MRI study will include pulmonary veins angiography with gadolinium injection (0.20 mmol/kg), 2D-cine imaging and late-enhancement imaging. A 3D gradient-echo sequence(Flash 3-D) will then be applied 20 minutes after the injection, with the following parameters : echo time 0.98 ms, repetition time 2.53 ms, angle 15°, resolution 2.0x1.3x1.0 mm. T1 map and two T2 sequences will be performed so as to determine LA relaxation times. Argus software will be used for post-treatment imaging. Quantitative data will be expressed in mean ± SD. A comparison of T1 and T2 values in LA will be performed between the three groups. Statistics will be performed with SPSS software in bilateral analysis and a value of p < 0.05 will be considered as significant.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All persons > 18 years, which have:
  • gp paroxysmal or persistant FA
  • paroxysmal or persistent FA (under one year),
  • refractory to at least one antiarrhythmic drug therapy
  • eligible for an ablation procedure with cryotherapy
  • the patient may benefit from surveillance. gp permanent FA permanent AF ( defined as chronic arrhythmia after 2 failed attempts to electrical cardioversion and / or more than one year old) , and hospitalized for cardiac reasons or not in different cardiology Timone .

排除标准

  • age < 18 years,
  • cons -indications to MRI ( claustrophobia, pacemakers and implantable cardiac defibrillators , metal chips intra ocular , valvular mechanical prosthesis ) , allergy to gadolinium ,
  • renal impairment ( creatinine clearance <60 mL / min)
  • pregnant or nursing ( a pregnancy test must be performed for women of childbearing age at the time of inclusion , the result of this test will be communicated to them .
  • the MRI examination takes place three months after the inclusion women of childbearing potential should be placed under effective contraception)

研究组 & 干预措施

a control group

Active Comparator

干预措施: MRI 3T (Device)

patients with paroxysmal or persistent AF

Experimental

干预措施: MRI 3T (Device)

patients with permanent AF

Experimental

干预措施: MRI 3T (Device)

结局指标

主要结局

quantitative measure of atrial fibrosis

时间窗: 4 years

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验